Press
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track Record
• Closing the gap between basic research and clinical application
• More than 50 percent of all funded projects received follow-up funding
Natur + Medizin
Neue Dauerausstellung ab 18. April im Senckenberg Forschungsinstitut und Naturmuseum Frankfurt
Else Kröner Fresenius Center for Optogenetic Therapies approved
Else Kröner Fresenius Foundation supports new research center for optogenetic therapies with 37.4 million euros over ten years at the University Medical Center Göttingen (UMG). State of Lower Saxony is strongly supporting the establishment of the center and, together with the UMG, is holding out the prospect of up to 22.6 million euros in additional funding. The new research building with costs of 32.7 million euros will be included in the construction planning by the state of Lower Saxony. The aim of the center is to develop innovative treatment approaches for patients suffering from deafness, blindness, gastric paralysis or movement deficits. The center will be integrated into the UMG.
Reentry after pause phase for family made easier
Funding amounting to a total of 1.2 million euros awarded for physicians following parental or family-care leave